News Bulletin
Thursday Jan 17, 2019
Evening Edition
Economic
Numbers
|
TIME |
DETAIL |
SURV |
PRIOR |
|
|
08:30 |
213K |
216K |
|
|
|
08:30 |
17.0 |
9.1 |
|
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
|
|
- |
- |
- |
|
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
S&P 500 |
2,636.23 |
- |
- |
|
DJIA |
24,370.54 |
- |
- |
|
NASDAQ |
7,084.61 |
- |
- |
17th Jan, 2019 Market News
07:55 Morgan Stanley [MS] slumps -5.7% in premarket
trading as Q4 adjusted EPS of 73 cents misses the average analyst estimate of 89
cents as the quarter's market swings dented results in fixed income sales and
trading.
08:33 The USPTO issues Notice of Allowance to RedHill Biopharma [RDHL] (+4%) for a new patent covering TALICIA (RHB-105),for H. pylori Infection. The patent will be valid until at least 2034.
08:36 Nobilis Health [HLTH] (-35%) has named current SVP of Finance, Brandon Moreno, as the Company's CFO, effective immediately.
08:51 TravelCenters of America [TA] (+14.1%) announces it agreed to acquire certain travel center properties from Hospitality Properties Trust (NYSE:HPT) and amend some leases.
08:54 CorMedix [CRMD] is up +16% premarket on above-average volume following its announcement of positive results from a Phase 3 clinical trial, LOCK-IT-100, evaluating its Neutrolin catheter lock solution in hemodialysis patients.
11:10 Barclays
downgrades Quantenna Communications [QTNA] (-14%) from
Equal-Weight to Underweight and cuts the target from $17 to the Street-low $14.
11:32 Signature Bank [SBNY] (+6.5%)
reports Q4 net interest income increase 4.8% Y/Y to $335M,
primarily due to growth in average interest-earning assets
11:34 Thinly traded nano
cap PLx Pharma [PLXP] (+26.3%) is up
on more than a 7x surge in volume, albeit on turnover of only 274K shares. The
stock is up over five-fold since touching $1.00 on December 27, 2018.
12:56 Limbach Holdings [LMB] (+4.6%) announced that it was awarded contracts totaling $81.4M in the aggregate to perform the mechanical and plumbing preconstruction and construction services on four hospitals projects.
13:49 KeyBanc thinks ForeScout [FSCT] (+4.8%) will report an upside surprise in Q4 and names the company as one of the firm's "key 2019 ideas." Analyst Rob Owens says ForeScout is "poised to capture a disproportionate share" of IoT security and has continued growth in enterprise-connected devices.
15:40 Five Prime Therapeutics [FPRX] (+7%) is up on average volume following its announcement of Phase 1 data on bemarituzumab + the chemo regimen mFOLFOX6 in heavily pretreated patients with metastatic gastric cancer whose tumors overexpress an oncogene called FGFR2b (~35% of gastric cancer cases). The results were presented at the ASCO GI Cancers Symposium in San Francisco.